Tryptophan, adenosine, neurodegeneration and neuroprotection.

Tryptophan, adenosine, neurodegeneration and neuroprotection. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Tryptophan, adenosine, neurodegeneration and neuroprotection. Abstract Text:

T W Stone,C M Forrest,G M Mackay,N Stoy,L G Darlington,T W Stone,C M Forrest,G M Mackay,N Stoy,L G Darlington,

This review summarises the potential contributions of two groups of compounds to cerebral dysfunction and damage in metabolic disease. The kynurenines are oxidised metabolites of tryptophan, the kynurenine pathway being the major route for tryptophan catabolism in most tissues. The pathway includes quinolinic acid -- an agonist at N-methyl-D-aspartate (NMDA) receptors, kynurenic acid -- an antagonist at glutamate and nicotinic receptors, and other redox active compounds that are able to generate free radicals under many physiological and pathological conditions. The pathway is activated in immune-competent cells, including glia in the central nervous system, and may contribute substantially to delayed neuronal damage following an infarct or metabolic insult. Adenosine is an ubiquitous purine that can protect neurons by suppressing excitatory neurotransmitter release, reducing calcium fluxes and inhibiting NMDA receptors. The extent of brain injury is critically dependent on the balance between the two opposing forces of kynurenines and purines.

Tryptophan, adenosine, neurodegeneration and neuroprotection. Publishing Authors By Initials

TW Stone,CM Forrest,GM Mackay,N Stoy,LG Darlington,TW Stone,CM Forrest,GM Mackay,N Stoy,LG Darlington,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Tryptophan, adenosine, neurodegeneration and neuroprotection. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Metabolic brain disease

VOLUME: 22

Page Numbers: 337-52

Journal Abbreviation:

ISSN: 0885-7490

DAY: 23

MONTH: Dec

YEAR: 2007

Tryptophan, adenosine, neurodegeneration and neuroprotection. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8610370

Tryptophan, adenosine, neurodegeneration and neuroprotection. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Tryptophan, adenosine, neurodegeneration and neuroprotection. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Tryptophan, adenosine, neurodegeneration and neuroprotection.

AFFILIATION: Institute of Biomedical & Life Sciences, West Medical Building, University of Glasgow, Glasgow, Scotland, UK. t.w.stone@bio.gla.ac.uk

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Metab Brain Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Tryptophan, adenosine, neurodegeneration and neuroprotection Related Publications

• Adenosine and cytokine levels following treatment of rheumatoid arthritis with dipyridamole.
• Alterations in xenobiotic metabolism in the long-lived Little mice.
• Blood and speech.
• Comparative field performance over 3 years and two sites of transgenic wheat lines expressing HMW subunit transgenes.
• Cytosolic glucocorticoid receptor expression in the rat vestibular nucleus and hippocampus following unilateral vestibular deafferentation.
• Effects of intra-vestibular nucleus injection of the group I metabotropic glutamate receptor antagonist AIDA on vestibular compensation in guinea pigs.
• Genetic particles.
• Glutamate receptor subunits expression in memory-associated brain structures: Regional variations and effects of aging.
• Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin.
• Lymphoid neogenesis and immune infiltration in aged liver.
• MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis.
• Medical history, sexual, and maturational factors and prostate cancer risk.
• Oral tumors.
• Osteonecrosis at multiple sites in a patient with systemic lupus erythematosus.
• Overview of research on health-related quality of life in patients with chronic liver disease.
• Quantitative changes in gene expression of glutamate receptor subunits/subtypes in the vestibular nucleus, inferior olive and flocculus before and following unilateral labyrinthectomy in the rat: real-time quantitative PCR method.
• Reproductive versatility in Rubus; raspberry-blackberry hybrids; on an integrated species difference.
• The changing face of insulin receptors.
• The contribution of nitric oxide to vestibular compensation: are there species differences?
• The effect of delta 9-tetrahydrocannabinol on the extinction of an adverse associative memory.
• The geographical distribution of cold-blooded vertebrates.
• The geographical distribution of cold-blooded vertebrates.
• The plasmagene theory of the origin of cancer.
• The transcription factor HNF1 acts with C/EBP alpha to synergistically activate the human albumin promoter through a novel domain.
• Threat of disease in tropical crops.
• Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers.
• Tryptophan, adenosine, neurodegeneration and neuroprotection.